Follow us on:
Breaking News
July 17, 2026
CP Direct: Friday Edition
Breaking News
FederalEquipment_ENL_070326_650x90
Next Week at Contract Pharma
Adare_Webinar_07-22-26_NextWeek@

Merck Opens €25 million BioReliance Testing Facility in Darmstadt, Germany

 
Merck Opens €25 million BioReliance Testing Facility in Darmstadt, Germany

New 2,000-square-meter facility expands Merck’s global testing network with commercial drug substance and drug product release testing and GMP-compliant stability studies.
Read More >>

Top Headlines

Breaking News

Lilly to Acquire AtaiBeckley

Deal adds AtaiBeckley’s BPL-003, a Phase 3-ready intranasal treatment for treatment-resistant depression, to Lilly’s neuroscience pipeline.

SPONSOR

Tailored CDMO Support That Reduces Risk and Delays

No two injectables are alike. Learn how flexible CDMO partnerships cut risk, speed timelines, and protect product integrity from vial to patient.

Breaking News
Trials & Filings

EU Approves Wegovy Pill for Weight Loss

Novo Nordisk’s oral semaglutide becomes the first GLP-1 tablet authorized for weight management across the EU.

Breaking News
Collaborations & Alliances

OXB Signs AAV Manufacturing Deal with Plowshare Therapies

Agreement covers process development and GMP manufacturing for Plowshare’s AAV-based rare disease program.

SPONSOR

[VideoBite] Overcoming Solubility Challenges at Hovione’s Expanded NJ Site

David Basile of Hovione discusses expanded spray drying capacity in East Windsor and the benefits of integrated development, scale-up, and manufacturing at a single U.S. site.

Ensera_ENL_071726_650x250

Breaking News
Collaborations & Alliances

Circio, Avenue Biosciences Partner on Gene Therapy Protein Expression

Collaboration combines Circio’s circVec platform with Avenue’s protein engineering technology to improve secretion of therapeutic proteins.

Online Exclusives

By the Numbers: Top 10 Pharma & Biopharma Companies

For the first time, Lilly takes the top spot with $65.2 billion in pharmaceutical sales.

Featured Resources

Solution Content Center SPOTLIGHT

Upperton

Upperton is a UK-based CDMO providing integrated contract development and manufacturing services. Specializing in oral, nasal, pulmonary and sterile dosage forms, Upperton offers a comprehensive range of services designed to support the progression of a molecule from early feasibility through to formulation development, clinical trial manufacture and commercial manufacture.

 

Solution Center SPOTLIGHT

SGS North America, Inc.

SGS supports pharmaceutical and biopharmaceutical clients from development through commercialization with a comprehensive portfolio of expert-led GMP quality control and analytical testing services for raw materials, APIs, packaging components, and finished drug products. Our teams apply disciplined science and regulatory expertise across small and large molecule programs to support product characterization, comparability, stability, and final GMP product release.